Compare Novo Nordisk A/S (NVO) vs Vale SA (VALE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Vale SA — how do they compare? Novo Nordisk A/S trades at $45.84 (market cap $207.85B), while Vale SA trades at $14.39 (market cap $61.97B). The key difference: Novo Nordisk A/S is far larger — about 3.4× Vale SA's market cap, and Vale SA pays the higher dividend (8.35%). Which is the better fit depends on your goals.
| NVO | VALE | |
|---|---|---|
Market Cap | $207.85B | $61.97B |
Sector | Health | Basic Materials |
52-Week High | $63.98 | $17.82 |
52-Week Low | $35.29 | $9.71 |
Enterprise Value | $222.55B | $78.22B |
Dividend Yield | 3.81% | 8.35% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Vale SA
Vale is the world's largest iron ore miner and one of the largest diversified miners, along with BHP and Rio Tinto. Earnings are dominated by the bulk materials division, primarily iron ore and iron ore pellets, with minor contributions from iron ore proxies, including manganese and coal. The base metals division is much smaller, primarily consisting of nickel mines and smelters with a small contribution from copper.
Read more on VALE →
